查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1943683

跳蚤和蜱蟲防治產品市場－全球產業規模、佔有率、趨勢、機會及預測（按類型、寵物類型、分銷管道、地區和競爭格局分類，2021-2031年）

Flea and Tick Products Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Pet Type, By Distribution Channel, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球跳蚤和蜱蟲防治產品市場預計將從 2025 年的 89.7 億美元成長到 2031 年的 154.7 億美元，複合年成長率為 9.51%。

這些產品包括各種化學或天然配方，例如口服藥物、外用溶液、噴霧劑和項圈，旨在防治和預防伴侶動物的體外寄生蟲感染。推動這一成長的關鍵因素是寵物日益人性化以及公眾對寄生蟲疾病的認知不斷提高，這兩點都促使飼主更加重視預防性獸醫護理。與產品偏好的變化不同，這些根本促進因素已經建立起以家庭安全和動物福利為基礎的基本需求水準。

市場概覽
預測期 2027-2031
市場規模：2025年 89.7億美元
市場規模：2031年 154.7億美元
複合年成長率：2026-2031年 9.51%
成長最快的細分市場 貓
最大的市場 北美洲

儘管成長前景樂觀，但市場仍面臨許多挑戰，包括嚴格的法規環境和仿冒品的氾濫，這些都威脅著消費者的信任和安全標準。然而，在必要的醫療保健支出支撐下，該行業保持著強勁的財務韌性。美國寵物用品協會報告稱，到2024年，美國寵物產業在獸醫護理和產品銷售方面的總支出將達到398億美元，這充分體現了人們對動物健康的堅定承諾。這項巨額投資表明，寵物飼主將動物保健和保護解決方案視為重中之重，確保了該市場在面臨營運挑戰的情況下仍能保持活力。

市場促進因素

寵物人性化和優質化的趨勢日益加速，成為市場成長的主要催化劑。飼主越來越將他們的伴侶動物視為家庭成員，並認為它們應該享受一流的醫療保健。這種文化轉變促使人們願意用更優質、更便利的產品來取代基礎的功能性治療，例如偏好極佳的咀嚼片和持久耐用的項圈。根據歐洲寵物用品及配件聯合會（FEDIAF）於2024年6月發布的《2024年事實與數據》報告，目前歐洲家庭飼養寵物的數量高達3.52億隻，這構成了一個龐大的飼主更有可能採取預防性健康策略。因此，製造商正致力於開發便捷的給藥方法和綜合療法，以滿足這些愛寵物飼主的生活方式和舒適度需求。

此外，氣候變遷正成為關鍵的環境因素，擴大了寄生蟲的季節性和地理分佈範圍，因此需要將策略從季節性防護轉向全年通訊協定。全球暖化使得跳蚤和蜱蟲能夠在以前未受影響的地區生存，並在冬季保持活躍，從而增加了紅血病和萊姆病等媒介傳播疾病的風險。根據伴侶動物寄生蟲委員會 (CAPC) 於 2024 年 4 月發布的《2024 年寵物寄生蟲預測》，蜱傳疾病和心絲蟲病的威脅持續向西北方向蔓延至非流行地區，這更加凸顯了持續預防的必要性。這種生物壓力確保了領先製藥公司穩定的收入。例如，碩騰公司 (Zoetis) 報告稱，其伴侶動物產品組合在 2024 年第三季的收入為 24 億美元，這主要得益於其先進驅蟲產品線的持續需求。

市場挑戰

嚴格的法規結構，加上仿冒品的氾濫，構成了複雜的壁壘，嚴重阻礙了全球跳蚤和蜱蟲防治產品市場的成長。政府對化學品功效和安全性的嚴格監管迫使製造商投入大量時間和資金進行產品檢驗。這種沉重的合規負擔減緩了創新速度，阻礙了企業快速推出對抗新出現的寄生蟲抗藥性所需的先進配方。因此，高准入門檻限制了市場彈性，並延緩了新產品線的產生收入。根據美國動物健康研究所 (AHI) 2024 年的報告，一種新的伴侶動物用藥品要獲得完整的核准流程，平均需要 6.5 年的研發時間和 2,250 萬美元的投資才能達到聯邦標準。

同時，仿冒品的氾濫貶低了合法市場的價值，並威脅到動物福利。這些非法產品外觀往往與合法品牌完全相同，卻繞過了安全測試，可能導致寵物出現不良反應。此類不安全替代品的氾濫削弱了消費者對整個產業的信任。當寵物飼主對現有治療方法的安全性缺乏信心時，他們往往會降低預防性治療的依從性，或猶豫是否購買優質產品，從而導致潛在市場萎縮，並阻礙了市場成長。

市場趨勢

電子商務和消費者訂閱模式的擴張正在從根本上改變市場動態，將分銷管道從傳統獸醫診所轉移到確保藥物持續使用的數位平台。這種通路轉變的特點是訂閱配送服務的廣泛應用，從而確保了持續的收入，並降低了人工採購週期中可能出現的供應缺口風險。大型線上零售商正利用這種持續的消費行為來獲取可觀的市場佔有率。例如，Chewy在2024年12月發布的「2024年第三季財報電話會議紀錄」中報告稱，自動續訂客戶的銷售額達到23億美元，佔總淨銷售額的80%，這證實了寵物健康領域消費者對自動補貨服務的強烈偏好。

此外，多效合一頻譜複方製劑的普及標誌著價值策略的趨同，單劑量配方即可同時防治體內外寄生蟲，佔據了消費者支出的大部分。與需要多次給藥的傳統治療方法不同，這些三效合一產品只需一次咀嚼即可提供全面保護，有效替代了跳蚤、蜱蟲和心絲蟲的單獨預防藥物，從而推動了財務成長。這種轉變正在為擁有已通過核准複方製劑的大型製藥公司創造一個收入集中的市場格局。例如，碩騰公司在2024年11月的「2024年第三季」財報電話會議上宣布，其三效合一產品Simparica Trio在美國的銷售額成長了29%，達到2.37億美元，這表明這些多功能解決方案正在迅速獲得商業性認可。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球跳蚤和蜱蟲防治產品市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依類型（口服錠劑、噴霧劑、滴劑、粉末、洗髮精、項圈、咀嚼片、其他）
    • 寵物類型（貓、狗、其他）
    • 按分銷管道（線下、線上）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美跳蚤和蜱蟲防治產品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲跳蚤和蜱蟲防治產品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區跳蚤和蜱蟲防治產品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲跳蚤和蜱蟲防治產品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲跳蚤和蜱蟲防治產品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

13. 全球跳蚤和蜱蟲防治產品市場：SWOT 分析

第14章 波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Ceva Animal Health, LLC
  • Elanco Animal Health Incorporated
  • Virbac SA
  • Boehringer Ingelheim International GmbH
  • Eli Lilly and Company
  • PetIQ, LLC
  • The Hartz Mountain Corporation
  • Kittrich Corporation
  • Central Garden & Pet Company
  • Merck & Co., Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 16027

The Global Flea and Tick Products Market is projected to expand from USD 8.97 Billion in 2025 to USD 15.47 Billion by 2031, reflecting a Compound Annual Growth Rate (CAGR) of 9.51%. These products encompass various chemical or natural formulations, including oral medications, topical solutions, sprays, and collars, intended to eradicate and prevent external parasite infestations on companion animals. The primary forces propelling this growth include the rising trend of pet humanization and increased public awareness concerning parasite-transmitted diseases, both of which urge owners to prioritize preventative veterinary care. Distinct from shifting product preferences, these fundamental drivers establish a baseline level of essential demand rooted in household safety and animal welfare.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 8.97 Billion
Market Size 2031USD 15.47 Billion
CAGR 2026-20319.51%
Fastest Growing SegmentCat
Largest MarketNorth America

Despite positive growth prospects, the market faces significant hurdles, specifically a rigorous regulatory environment and the spread of counterfeit goods which threaten consumer confidence and safety standards. Nevertheless, the sector maintains strong financial resilience driven by essential health expenditures. As evidence of this unwavering commitment to animal health, the American Pet Products Association reported in 2024 that United States pet industry spending specifically for veterinary care and product sales totaled $39.8 billion. This considerable investment underscores the high priority pet owners assign to medical and protective solutions for their animals, ensuring sustained market relevance despite operational challenges.

Market Driver

The escalating trend of pet humanization and premiumization acts as a major catalyst for market growth, as owners increasingly treat companion animals as core family members requiring top-tier healthcare. This cultural evolution fosters a willingness to purchase superior, user-friendly formulations like palatable chews and long-lasting collars, replacing basic functional treatments. According to the 'Facts & Figures 2024' report released by FEDIAF in June 2024, European households currently care for 352 million pets, creating a vast demographic of owners statistically more likely to adopt preventative health strategies. Consequently, manufacturers are focusing on developing convenient application methods and combination therapies that suit the lifestyles and comfort requirements of these dedicated pet parents.

Additionally, climate change acts as a critical environmental driver by extending the seasonality and geographical range of parasites, necessitating a strategic transition from seasonal to year-round protection protocols. Rising global temperatures enable fleas and ticks to survive in previously unaffected regions and remain active during winter, heightening the risk of vector-borne illnesses such as ehrlichiosis and Lyme disease. According to the Companion Animal Parasite Council's '2024 Pet Parasite Forecast' from April 2024, the threat of tick-borne diseases and heartworm has continued to expand northward and westward into non-endemic areas, reinforcing the need for continuous prophylaxis. This biological pressure guarantees consistent revenue for pharmaceutical leaders; for instance, Zoetis reported third-quarter 2024 revenue of $2.4 billion for its companion animal portfolio, largely fueled by sustained demand for its advanced parasiticide lines.

Market Challenge

The combination of a strict regulatory framework and the proliferation of counterfeit items presents a complex barrier that substantially impedes the growth of the global flea and tick products market. Rigid government mandates concerning chemical efficacy and safety compel manufacturers to invest significant time and capital into product validation. This heavy compliance load decelerates innovation, hindering companies from rapidly introducing advanced formulations required to combat emerging parasite resistance. As a result, high entry barriers restrict market agility and delay revenue generation from new lines; according to the Animal Health Institute in 2024, the full approval process for a new companion animal pharmaceutical averaged 6.5 years in development time and $22.5 million in investment to meet federal standards.

Concurrently, the widespread circulation of counterfeit merchandise diminishes legitimate market value and endangers animal welfare. These illicit products, frequently identical in appearance to authentic brands, evade safety testing and can induce adverse reactions in pets. The ubiquity of such dangerous alternatives undermines consumer confidence across the entire category. When pet owners lack trust in the safety of available treatments, they often decrease adherence to preventative regimens or hesitate to buy premium solutions, effectively contracting the total addressable market and stalling financial growth.

Market Trends

The expansion of e-commerce and direct-to-consumer subscription models is fundamentally reshaping market dynamics by moving distribution power from traditional veterinary clinics to digital platforms that ensure medication adherence. This channel shift is characterized by the broad adoption of auto-ship programs, which secure recurring revenue and reduce the risk of coverage gaps associated with manual purchasing cycles. Major online retailers are leveraging this consistent consumer behavior to seize significant market share. For example, Chewy reported in its 'Q3 2024 Earnings Call Transcript' from December 2024 that its Autoship customer sales hit $2.3 billion, accounting for 80% of total net sales, underscoring the strong consumer preference for automated replenishment within the pet health sector.

Furthermore, the proliferation of all-in-one broad-spectrum combination therapeutics signifies a strategic consolidation of value, where single-dose formulations addressing both internal and external parasites are securing the majority of consumer spending. Unlike legacy treatments that require multiple administrations, these triple-action products drive financial growth by providing comprehensive protection in a single chew, effectively replacing separate preventatives for fleas, ticks, and heartworm. This transition creates a concentrated revenue landscape for pharmaceutical leaders possessing approved comprehensive labels. As an illustration of this trend, Zoetis announced in its 'Third Quarter 2024 Financial Results' in November 2024 that revenue for its triple-combination product, Simparica Trio, rose by 29% in the U.S. to $237 million, demonstrating the rapid commercial adoption of these multi-modal solutions.

Key Market Players

  • Ceva Animal Health, LLC
  • Elanco Animal Health Incorporated
  • Virbac S.A.
  • Boehringer Ingelheim International GmbH
  • Eli Lilly and Company
  • PetIQ, LLC
  • The Hartz Mountain Corporation
  • Kittrich Corporation
  • Central Garden & Pet Company
  • Merck & Co., Inc.

Report Scope

In this report, the Global Flea and Tick Products Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Flea and Tick Products Market, By Type

  • Oral Pill
  • Spray
  • Spot On
  • Powder
  • Shampoo
  • Collar
  • Chewable
  • Others

Flea and Tick Products Market, By Pet Type

  • Cat
  • Dog
  • Others

Flea and Tick Products Market, By Distribution Channel

  • Offline
  • Online

Flea and Tick Products Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Flea and Tick Products Market.

Available Customizations:

Global Flea and Tick Products Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Flea and Tick Products Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Oral Pill, Spray, Spot On, Powder, Shampoo, Collar, Chewable, Others)
    • 5.2.2. By Pet Type (Cat, Dog, Others)
    • 5.2.3. By Distribution Channel (Offline, Online)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Flea and Tick Products Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Pet Type
    • 6.2.3. By Distribution Channel
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Flea and Tick Products Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Pet Type
        • 6.3.1.2.3. By Distribution Channel
    • 6.3.2. Canada Flea and Tick Products Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Pet Type
        • 6.3.2.2.3. By Distribution Channel
    • 6.3.3. Mexico Flea and Tick Products Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Pet Type
        • 6.3.3.2.3. By Distribution Channel

7. Europe Flea and Tick Products Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Pet Type
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Flea and Tick Products Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Pet Type
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. France Flea and Tick Products Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Pet Type
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. United Kingdom Flea and Tick Products Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Pet Type
        • 7.3.3.2.3. By Distribution Channel
    • 7.3.4. Italy Flea and Tick Products Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Pet Type
        • 7.3.4.2.3. By Distribution Channel
    • 7.3.5. Spain Flea and Tick Products Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Pet Type
        • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Flea and Tick Products Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Pet Type
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Flea and Tick Products Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Pet Type
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. India Flea and Tick Products Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Pet Type
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. Japan Flea and Tick Products Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Pet Type
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. South Korea Flea and Tick Products Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Pet Type
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Australia Flea and Tick Products Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Pet Type
        • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Flea and Tick Products Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Pet Type
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Flea and Tick Products Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Pet Type
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. UAE Flea and Tick Products Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Pet Type
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. South Africa Flea and Tick Products Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Pet Type
        • 9.3.3.2.3. By Distribution Channel

10. South America Flea and Tick Products Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Pet Type
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Flea and Tick Products Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Pet Type
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Colombia Flea and Tick Products Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Pet Type
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. Argentina Flea and Tick Products Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Pet Type
        • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Flea and Tick Products Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Ceva Animal Health, LLC
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Elanco Animal Health Incorporated
  • 15.3. Virbac S.A.
  • 15.4. Boehringer Ingelheim International GmbH
  • 15.5. Eli Lilly and Company
  • 15.6. PetIQ, LLC
  • 15.7. The Hartz Mountain Corporation
  • 15.8. Kittrich Corporation
  • 15.9. Central Garden & Pet Company
  • 15.10. Merck & Co., Inc.

16. Strategic Recommendations

17. About Us & Disclaimer